Cipher Pharmaceuticals Stock Forward View - Unknown Technical Ratio
| CPH Stock | CAD 16.56 -0.01 -0.06% |
The Debt To Equity reference data for Cipher Pharmaceuticals is derived from the equity's published trading history. The resulting forecast and deviation statistics are presented as reference data for informational context. Forecast values and accuracy statistics are presented for informational purposes.
The forecast reference data presented here for Cipher Pharmaceuticals reflects Debt To Equity model output and is intended as reference material for analytical use. Debt To Equity Analysis Today
Cipher Pharmaceuticals has current Debt To Equity of 0.| Volatility | Backtest | Information Ratio |
Cipher Pharmaceuticals Trading Date Momentum
| On March 23 2026 Cipher Pharmaceuticals was traded for 16.56 at the closing time. The maximum traded price for the trading interval was 16.95 and the lowest daily price was 16.50 . The daily volume was recorded at 37.7 K. The volume of trading on 23rd of March 2026 did not affect price variability. The overall trading delta to the closing price today is -0.36% . |
| Compare Cipher Pharmaceuticals to competition |
Other Forecasting Options for Cipher Pharmaceuticals
Fibonacci retracement levels applied to Cipher Stock price swings identify potential support and resistance zones. Extreme price moves in Cipher occur more frequently than standard risk models assume. Support and resistance levels derived from Cipher Pharmaceuticals' historical data identify zones where buying or selling pressure has stalled moves.Cipher Pharmaceuticals Related Equities
Checking Cipher Pharmaceuticals against related firms within the Health Care space helps investors see where the stock stands among peers. Looking at Cipher Pharmaceuticals' pricing multiples next to these peers shows if the stock trades at a premium or discount.
| Risk & Return | Correlation |
Cipher Pharmaceuticals Market Strength Events
Tracking market strength indicators for Cipher Pharmaceuticals provides context for understanding stock momentum dynamics. Tracking these indicators helps identify periods where trading Cipher Pharmaceuticals is likely to be most rewarding. These tools are essential for timing trades in Cipher Pharmaceuticals with a quantitative framework.
Cipher Pharmaceuticals Risk Indicators
Properly assessing Cipher Pharmaceuticals' risk indicators is a prerequisite for building reliable price forecasts. This analysis provides context for determining the appropriate level of risk to accept when holding Cipher Pharmaceuticals'. Analyzing Cipher Pharmaceuticals' risk indicators provides a critical input for investment risk management.
| Mean Deviation | 1.71 | |||
| Semi Deviation | 1.33 | |||
| Standard Deviation | 2.8 | |||
| Variance | 7.82 | |||
| Downside Variance | 2.42 | |||
| Semi Variance | 1.76 | |||
| Expected Short fall | -2.46 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cipher Pharmaceuticals
A coverage review of Cipher Pharmaceuticals shows when the security is attracting above-average attention from contributors and market observers. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.
Story Categories
Currently Trending Categories
Cipher Pharmaceuticals Short Properties
Short-interest signals around Cipher Pharmaceuticals can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
| Common Stock Shares Outstanding | 26 M | |
| Cash And Short Term Investments | 7.5 M |
More Resources for Cipher Stock Analysis
Other Information on Investing in Cipher Stock
Financial ratios for Cipher Pharmaceuticals organize key financial data into structured relationships. This format maintains consistency across different reporting periods.